About MABDX
mAbDx is a company specializing in the development of monoclonal antibodies and immunoassays for diagnostic and research purposes, with a focus on diseases involving mitochondrial dysfunction and infectious agents. They have collaborated on studies published in scientific journals and have received SBIR grants for their research.
Development of monoclonal antibodies recognizing mtDNA-encoded OXPHOS proteinsCollaboration on Imaging Mass Cytometry (IMC) studies for disease researchCreation of rapid point-of-care diagnostic testsConsulting services for antibody and immunoassay developmentDesign and application of novel screening protocols and assay platforms
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MABDX right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.